-
Creative Biolabs Introduces One-Stop CAR-T Preclinical In Vivo Assay Services
Sep 6, 2020, 23:56 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Sep 7, 2020 - Chimeric antigen receptor (CAR) T cell therapy represents the culmination of research in both immunology and oncology fieldsFull story -
Mouse Models, Machine Learning, Triggering Proteins: COVID-19 Updates
Sep 4, 2020, 04:25 AM by Michael CroftBio-IT World A potential new screening approach, improving immune response to vaccines, new mouse models of SARS-CoV-2, exploring ACE2 receptor activity, a protein that may trigger blood clots, the importance of placenta tissue, hopeful signs that a single vaccine can do the job, and a bioengineering technique to boost production of proteins that prompt antibody development. Plus, machine learning to help identify drug combinations that can be repurposed as potential therapies.Full story -
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Sep 3, 2020, 16:15 PM by Michael CroftBOSTON, MA - Sep 3, 2020 - Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2,[1] with participation by existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBIFull story -
Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma
Sep 3, 2020, 07:54 AM by Michael CroftAMSTERDAM, THE NETHERLANDS - Sep 3, 2020 - : CPhI Festival of Pharma (5-16 October, 2020), the worlds largest ever virtual pharma expo, unveils its ground-breaking two-week long agendaFull story -
Phil Baran on the Quest to Make Chemistry Boring Again
Sep 3, 2020, 01:10 AM by Michael CroftBio-IT World | Phil Baran of Scripps Research is dedicated to simplifying chemical synthesis, not to create techniques that are “gimmicky” but will instead become the standard processes of the future. Maybe, “fifty years from now,” he predicts, “we’ll look back in curiosity at chemists of our age who had stages in their syntheses instead of making everything in 1-3 steps.”Full story -
Truth Challenge v2: Latest Challenge Results From Genome In A Bottle
Sep 2, 2020, 13:30 PM by Michael CroftBio-IT World PrecisionFDA and The Genome in a Bottle (GIAB) consortium have announced the results of the Truth Challenge V2: Calling Variants from Short and Long Reads in Difficult-to-Map Regions such as segmental duplications, and the Major Histocompatibility Complex (MHC).Full story -
Senior team at healthcare agency Page & Page become Partners
Sep 2, 2020, 10:53 AM by Michael CroftLONDON, UNITED KINGDOM - Sep 2, 2020 - Senior team at healthcare agency Page & Page become Partners Significant changes at Page & Page and Partners also include a new London office, a series of client wins and company growth during Covid London, UKxFull story -
AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Primary tabs
Sep 2, 2020, 05:23 AM by Michael CroftEDINBURGH, UNITED KINGDOM - Sep 2, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, announces the award of a £1Full story -
FamHis, Inc. Completes its Launch of the FamGenix Family Health History Platform
Sep 1, 2020, 14:33 PM by Michael CroftBOYNTON BEACH, FL - Sep 1, 2020 - FamHis, Inc. announces the completion and worldwide release of their next-generation family health history platform FamGenixFull story -
A Virtual Feast: A Preview of Bio-IT World 2020
Sep 1, 2020, 13:55 PM by Michael CroftBio-IT World | The 2020 Bio-IT World Conference & Expo Virtual includes three days full of content, networking, and interaction across 16 tracks, plenary session, workshops, posters, awards, and happy hours. And for the first time ever, many presentations will be available on demand after their first showing. We are already building our agenda.
CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management
Sep 1, 2020, 11:08 AM
by
Michael Croft
LOUVAIN-LA-NUEVE, BELGIUM - Sep 1, 2020 - CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management
Full story
Racial Impacts of COVID-19, Neutralizing Antibodies, More
Aug 28, 2020, 10:05 AM
by
Michael Croft
Bio-IT World | Racial segregation of COVID-19 is following HIV patterns, more data on neutralizing antibodies, four months of data from Italy's use of hydroxychloroquine, and a computer model for school launches. Plus, an award from the UK government for vaccine development.
CD Genomics Introduces Extended Panels for SARS-CoV-2 Detection and Research
Aug 28, 2020, 01:42 AM
by
Michael Croft
SHIRLEY, NY, UNITED STATES - Aug 28, 2020 - CD Genomics, a leader in sequencing, microarray analysis, library construction and genotyping, recently announced availability of its CDAMP® SARS-CoV-2 Panel Kit, CDCAP® β-CoVs Panel Kit and CDCAP® Respiratory Virus Panel Kit for SARS-CoV-2 detection and research via its predesigend NGS panels
Full story
UK Biobank Contracts With DNAnexus, AWS to Build Data Analysis Platform
Aug 26, 2020, 14:40 PM
by
Michael Croft
Bio-IT World UK Biobank, a long-term study of health data from 500,000 UK volunteers, announced today that it is developing its own cloud-based Data Analysis Platform to make its extensive medical data available to a broader range of researchers around the world. Funding for the Data Analysis Platform has come from Wellcome, and it will be developed over the next three years by DNAnexus in collaboration with Amazon Web Services (AWS).
Full story
Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners
Aug 26, 2020, 10:49 AM
by
Michael Croft
PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners
Full story
Vertiv, Pure Storage, And More: News From August 2020
Aug 25, 2020, 15:15 PM
by
Michael Croft
Bio-IT World August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Vertiv, Pure Storage, and more.
Full story
Aveshka announces Dr. Til Jolly as Chief Medical Officer
Aug 21, 2020, 21:24 PM
by
Michael Croft
WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the companys executive team in the newly created role of Chief Medical Officer (CMO)
Full story
Beetle Viruses, Nitrate Supplements, Missing Sense of Smell: COVID-19 Updates
Aug 21, 2020, 09:35 AM
by
Michael Croft
Bio-IT World | How a beetle virus is informing SARS-CoV-2 research, plus nitrate supplementation for aid breathing, new small molecules active against the virus, and a theory for why COVID-19 patients lose their sense of smell. Plus, $9.8 million from DOD for vaccine research and virus-like particles for vaccine development.
Full story
The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry
Aug 20, 2020, 23:49 PM
by
Michael Croft
NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management
Full story
AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment
Aug 20, 2020, 23:36 PM
by
Michael Croft
NY, NY - Aug 20, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database
Full story